FEIBA STIM4 Anti-Inhibitor Coagulant Complex 500 IU Vial, NovoSeven 1mg Injection, SIEMENS FACTOR VII
Indian Council of Medical Research · Mumbai, Maharashtra · Healthcare Services · open
Key facts
- Closing date: 27 Aug 2026
- Status: open
- Ministry: Ministry of Health and Family Welfare
- Department: Department of Health Research
- Office: Mumbai
Description
Tender for supply of various medical products including FEIBA, NovoSeven, SIEMENS Factor VIII, and related consumables, with a total quantity of 44 units, issued by the Indian Council of Medical Research under the Department of Health Research, Ministry of Health and Family Welfare.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
- Documents required: Experience/Turnover Certificates, OEM Authorization Certificate, Compliance Documents
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Item wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (6)
- FEIBA 500 IU Vial — Qty: 44 Vial
- NovoSeven 1mg Injection
- SIEMENS FACTOR VIII DEFICIENT PLASMA-1ML
- SIEMENS OWREN VERNOLBUFFER-15ML
- SIEMENS CALCIUM CHLORIDE 0.025mMOL L-15ML
- D-Dimer Catalog No.
1 tender document(s) available — sign up to download.